Group by:
Date |
Item TypeArticle
New approaches to pathogenesis and management of hypertension.
Ritz, E., Krum, H., Schlaich, M., Whitbourn, R., Sobotka, P.A., Sadowski, J., Bartus, K., Kapelak, B., Walton, A., Sievert, H., Thambar, S., Abraham, W.T., Esler, M., Wang, Y., Tsun, Z., Machnik, A., Neuhofer, W., Jantsch, J., Dahlmann, A., Tammela, T., Machura, K., Park, J.K., Beck, F.X., Mueller, D.N., Derer, W., Goss, J., Ziomber, A., Dietsch, P., Wagner, H., van Rooijen, N., Kurtz, A., Hilgers, K.F., Alitalo, K., Eckardt, K.U., Luft, F.C., Kerjaschki, D. and Titze, J.
Clinical Journal of the American Society of Nephrology 4
(12): 1886-1891.
December 2009
Niacin lowers serum phosphate and increases HDL cholesterol in dialysis patients.
Mueller, D., Mehling, H., Otto, B., Bergmann-Lips, R., Luft, F.C., Jordan, J. and Kettritz, R.
Clinical Journal of the American Society of Nephrology 2
(6): 1249-1254.
November 2007
Review
Direct renin inhibition with aliskiren in hypertension and target organ damage.
Mueller, D.N. and Luft, F.C.
Clinical Journal of the American Society of Nephrology 1
(2): 221-228.
March 2006
Editorial
More mixed messages in terms of salt.
Luft, F.C.
Clinical Journal of the American Society of Nephrology 4
(11): 1699-1700.
November 2009
Vasopressin, urine concentration, and hypertension: a new perspective on an old story.
Luft, F.C.
Clinical Journal of the American Society of Nephrology 2
(2): 196-197.
March 2007
This list was generated on Wed Jul 17 20:44:59 2024 UTC.